Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Total Non-Current Liabilities (2020 - 2025)

Firefly Neuroscience has reported Total Non-Current Liabilities over the past 5 years, most recently at $2.4 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $2.4 million for Q4 2025, down 43.05% from a year ago — trailing twelve months through Dec 2025 was $2.4 million (down 43.05% YoY), and the annual figure for FY2025 was $2.4 million, down 43.05%.
  • Total Non-Current Liabilities for Q4 2025 was $2.4 million at Firefly Neuroscience, down from $4.1 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for AIFF hit a ceiling of $5.0 million in Q4 2021 and a floor of $2.4 million in Q4 2025.
  • Median Total Non-Current Liabilities over the past 4 years was $4.1 million (2022), compared with a mean of $3.7 million.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 131.05% in 2021 and later plummeted 43.05% in 2025.
  • Firefly Neuroscience's Total Non-Current Liabilities stood at $5.0 million in 2021, then fell by 14.83% to $4.3 million in 2022, then dropped by 2.41% to $4.1 million in 2024, then crashed by 43.05% to $2.4 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $2.4 million (Q4 2025), $4.1 million (Q4 2024), and $4.3 million (Q4 2022) per Business Quant data.